Investors in Wellness

Act VC is an early-stage venture capital firm that partners with founders starting out, and established teams scaling their growth. We have raised over €600m across multiple funds to support this goal. We look for innovative, category-defining companies in large markets. We help founders build and scale these leveraging the experience of backing over 200 founders before. We work closely with them in this process. Over the past 25 years, we have invested in over 120 companies and built a broad global network.

Sprints provides growth capital to category winning, technology enabled companies. We make long-term focused investments in companies that have strong market positions and are managed by excellent teams with a passion to over-deliver to all their stakeholders. We have a long-term partner mindset in everything we do. It influences how we work with our investment partners, our portfolio companies, teams and co-investors. We work closely with our investments to support them in building durable market leading positions.

Generali Ventures is underway: with a dedicated commitment of €250 million, we aim to identify and invest in high-growth opportunities, particularly in the insurtech and fintech sectors. Generali Ventures is more than just a venture capital initiative: it is a testament to our commitment to innovation and our drive to transform the insurance sector. We are dedicated to staying at the forefront of emerging technologies and providing our customers with the best possible service. The initiative was designed to address challenges arising from the sector’s rapid evolution, evolving customer needs and significant global trends.

We're the UK's first VC firm for female founders. EARLY STAGE INVESTORS IN FEMALE-LED TECHNOLOGY COMPANIES. WE PARTNER WITH THE BEST ENTREPRENEURS AND HELP THEM BUILD LASTING COMPANIES.

Founded in 2018 Nordic Secondary Fund is the first and only fund in the Nordics to exclusively invest in secondaries. The Private Equity “Secondaries” asset class is an attractive alternative investment with high yields and is a source of diversification for investors to mitigate overall risk. Nordic Secondary Fund’s investment focus is exclusively on Nordic and Baltic companies, where the founder and key employees are domiciled. All startups have a proven and scalable business model, locally as well as globally.

Masawa invests in European startups catalyzing mental health and wellness. Our Nurture Capital approach minimizes risk, enhances founder wellbeing, repurposes capital, and optimizes financial and social returns.

Myelin VC is Investing in companies that accelerate collective intelligence. They collaborate with visionary outliers to pioneer the unimaginable, investing in founders whose ideas shape a future they envision living in. Their investment strategy spans across industries, from seed funding to Series A, supporting innovative ventures poised to disrupt and redefine their respective fields.

E14 Invest is a co-investment company based in Åre that invests in scalable growth companies with connections to the region along the European route E14, from Sundsvall to Trondheim. The goal is to favor entrepreneurship in the region while making long-term sustainable investments with good returns for our investors. We also make a smaller percentage of investments outside the region when it is particularly interesting.

Carl Westin is an international investment company. They invest in great people with big ideas. Industry agnostic-

They are a growth equity firm focused on empowering visionary founders who innovate in brands and tech-enabled solutions that improve lives while promoting inclusivity. They seek unstoppable founders who anticipate future challenges, emphasizing responsible innovation, diversity, transparency, and positive change. Operating as true partners, they offer extensive operational and strategic support, leveraging a broad network to enhance consumer experiences through community, branding, innovation, and technology. With a global outlook, they invest in Series A rounds and later-stage co-investments across Europe, the UK, US, and Asia, aiming to build a more human-centered digital-lifestyle future.

CG Health Ventures specializes in investing in innovative startups, particularly within Health IT, Digital Health, and Genomics sectors. They focus on early-stage projects, often at the concept stage, seeking entrepreneurs with ambitious visions and a resilient drive to achieve their goals. Emphasizing a strong values alignment, CG Health Ventures aims to forge effective and enjoyable working relationships with their portfolio companies. They actively engage with startups, leveraging their passion, experience, and network to provide hands-on support throughout the entrepreneurial journey. While they have a global outlook, their primary operational focus and network are centered in Europe and the US.